â¥18yrs: DPN: initially 50mg 3 times daily, may increase to 100mg 3 times daily within 1 week. Spinal cord injury: initially 75mg twice daily, may increase to 150mg twice daily within 1 week, then max 600mg/day after 2 weeks as tolerated. PHN: initially 75mg twice daily or 50mg 3 times daily; max 300mg/day after 1 week then 600mg/day after 2 weeks as tolerated (see literature). For all: renal impairment (CrCl <60mL/min): reduce dose (see literature); hemodialysis: give supplemental dose after session.
HexaTech is a privately-held company that operates in the Consumer Electronics industry. HexaTech was founded in 2001. HexaTech headquarters are located in Morrisville, North Carolina.
Vivek Ramaswamy continues to make waves in the biotech business with his deals and drug development plans. He was behind the biggest biotechnology initial public offering of 2016, Myovant Sciences, which raised $218 million listing its shares on Nasdaq in October. Ramaswamy formed the company in April and struck a deal with Takeda Pharmaceuticals for a prostate cancer drug and a female infertility drug. Last year, Ramaswamy pulled off the biggest IPO in U.S. biotech history by listing shares of Axovant, a company that is trying to develop a new Alzheimer's drug.